Stoke Therapeutics

$51.17
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$3.18 (+6.63%) Today
$0.00 (0.00%) As of 5:00 PM EST after-hours

Why Robinhood?

You can buy or sell STOK and other stocks, options, and ETFs commission-free!

About STOK

Stoke Therapeutics, Inc. Common Stock, also called Stoke Therapeutics, is a biotechnology company, which engages in the research and development of treatments for genetic diseases. It offers a wide range of relevant tissues, including the central nervous system, eye, kidney, and liver. The company was founded by Isabel Aznarez and Adrian R. Krainer in June 2014 and is headquartered in Bedford, MA. The listed name for STOK is Stoke Therapeutics, Inc. Common Stock.

CEO
Edward M. Kaye
Employees
56
Headquarters
Bedford, Massachusetts
Founded
2014
Market Cap
1.84B
Price-Earnings Ratio
Dividend Yield
Average Volume
265.77K
High Today
$53.00
Low Today
$48.95
Open Price
$49.21
Volume
81.11K
52 Week High
$53.00
52 Week Low
$15.82

Collections

STOK Earnings

-$1.54
-$1.03
-$0.51
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Mar 23, Pre-Market

You May Also Like